Specialists in quantifying the current and future burden of non-communicable and rare genetic diseases.
Our data-driven epidemiology generates evidence to support strategic planning, portfolio management, policy and advocacy, informing decisions across the drug development lifecycle and helping shape healthcare policy.
From molecule to market, our solutions can help.
Deep expertise in disease epidemiology combined with entrepreneurial vision. Our work has been widely published and peer-reviewed by world-leading experts.
Why Us?We’ve spent over a decade developing our methodology to help you ask the right questions and make the best decisions.
SolutionsWe’ve answered all kinds of questions for many different organisations, covering over 25 NCDs and rare genetic diseases in over 80 countries.
Track RecordOur experienced and multidisciplinary team brings together epidemiologists, geneticists, mathematicians, data scientists, researchers, and software engineers.
About Us
The autumn conference season is in full swing, and over the next few weeks the HealthLumen team will be out and about at events spanning rare disease, cardiovascular health, health policy and HEOR. First stop is the World Orphan Drug Congress Europe 2026 | Amsterdam Europe’s largest orphan drug & rare disease meeting. Harrison Goldspink will be […]
Read
From computational breakthrough to strategic decision-making – reflections from the World Congress of the International Microsimulation Association I recently attended the World Congress of the International Microsimulation Association (IMA), where researchers from around the world presented the latest advances in microsimulation across multiple fields. One thing immediately stood out. There was remarkably little representation from […]
Read
In many chronic diseases, the challenge is not simply estimating how many patients exist today, it is understanding how those patients will progress over time, and how that progression can be altered. Diseases such as chronic kidney disease (CKD) and other chronic conditions unfold over many years. Patients move through different stages, face different risks, […]
Read
“Prevention, prevention, prevention” – the rallying call from Sandra Gallina, Director General of DG SANTE at the European Commission, set the scene for the core theme that ran through the 10th Politico Health Care Summit in Brussels, on 18th and 19th November. The scale of the challenge The non-communicable disease (NCD) burden across Europe is […]
Read